Ben-Gurion University researchers develop innovative biosensor, team up with Israeli biotech company OncoHost in bid for FDA approval
Points: -24
Three-day annual conference, marking 20th year, brings together thousands of participants for newest innovations in medical and heath tech
Points: 3
Startup's blood test aims to predict which cancer patients will react better to treatment; 8 clinical trials will be set up in the UK
Points: 90
ONCOHOST, founded by the Technion's Yuval Shaked, is performing clinical trials; goal is to predict treatments' effectiveness and determine how to improve them, for each patient
Points: -6
Recent comments